News list for " biotechnology"
Lixte Biotechnology, a clinical-stage pharmaceutical company, closed down 16 percent Wednesday at $4.06 per share, according to Yahoo Finance, after announcing plans to allocate up to 25 percent of its reserves to bitcoin reserves. The sell-off from LIXT comes as investors appear to be switching from bitcoin to Ethereum reserve companies, which until recently were highly sought after, but with a wave of new companies...
据雅虎财经数据显示，临床阶段制药公司Lixte Biotechnology（股票代码：LIXT）周三收盘报4.06美元/股，下跌16%。此前，该公司宣布计划将最多25%的储备资金配置到比特币储备中。 LIXT的抛售潮出现之际，投资者似乎正从比特币转向以太坊储备类公司，因为ETH近期借助市场顺风表现优于全球最古老的加密货币。比特币储备类公司直到最近还备受追捧，但随着一批新公...
The board of directors of biopharmaceutical company LIXTE Biotechnology Holdings has approved a strategic capital allocation plan to invest up to 25% of the corporate treasury in cryptocurrencies, including bitcoin and other digital assets. The specific transaction size and timing will be determined based on market conditions and strategic considerations.
生物制药公司LIXTE Biotechnology Holdings董事会已批准战略资本分配计划，将企业财库的最高25%用于投资加密货币，包括比特币及其他数字资产。具体交易规模和时间将根据市场条件及战略考虑决定。
